These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22204001)

  • 41. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
    Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
    BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing.
    Tadié JM; Bae HB; Banerjee S; Zmijewski JW; Abraham E
    Am J Physiol Cell Physiol; 2012 Jan; 302(1):C249-56. PubMed ID: 22012330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation.
    Komai K; Shichita T; Ito M; Kanamori M; Chikuma S; Yoshimura A
    Int Immunol; 2017 Feb; 29(2):59-70. PubMed ID: 28338748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The receptor mechanism of high mobility group box-1 protein induced apoptosis in peritoneal macrophages in mice].
    Liu F; Yao YM; Dong N; Xu S; Sheng ZY
    Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):432-5. PubMed ID: 18457255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.
    Zhang Y; Karki R; Igwe OJ
    Biochem Pharmacol; 2015 Nov; 98(1):132-43. PubMed ID: 26367307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone.
    Liu L; Ling X; Tang H; Chen J; Wen Q; Zou F
    Chem Biol Interact; 2015 Aug; 238():1-8. PubMed ID: 26047893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The HMGB1 receptor RAGE mediates ischemic brain damage.
    Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
    J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
    Kanai M; Hanashiro K; Kim SH; Hanai S; Boulares AH; Miwa M; Fukasawa K
    Nat Cell Biol; 2007 Oct; 9(10):1175-83. PubMed ID: 17891139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
    Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR
    Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor 4 engagement inhibits adenosine 5'-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism.
    Tadie JM; Bae HB; Deshane JS; Bell CP; Lazarowski ER; Chaplin DD; Thannickal VJ; Abraham E; Zmijewski JW
    Mol Med; 2012 May; 18(1):659-68. PubMed ID: 22396017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of high-mobility group box 1 protein and poly(ADP-ribose) polymerase 1 degradation in Chlamydia trachomatis-induced cytopathicity.
    Yu H; Schwarzer K; Förster M; Kniemeyer O; Forsbach-Birk V; Straube E; Rödel J
    Infect Immun; 2010 Jul; 78(7):3288-97. PubMed ID: 20421386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic T Cell Exhaustion Dynamics Is Linked to Early High Mobility Group Box Protein 1 (HMGB1) Driven Hyper-Inflammation in a Polytrauma Rat Model.
    Muire PJ; Schwacha MG; Wenke JC
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
    Ghosh U; Das N; Bhattacharyya NP
    Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
    Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl)ation in regulation of centrosome function.
    Kanai M; Tong WM; Sugihara E; Wang ZQ; Fukasawa K; Miwa M
    Mol Cell Biol; 2003 Apr; 23(7):2451-62. PubMed ID: 12640128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracellular HMGB1 negatively regulates efferocytosis.
    Banerjee S; de Freitas A; Friggeri A; Zmijewski JW; Liu G; Abraham E
    J Immunol; 2011 Nov; 187(9):4686-94. PubMed ID: 21957148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review: Therapeutic Targeting of HMGB1 in Stroke.
    Tian X; Liu C; Shu Z; Chen G
    Curr Drug Deliv; 2017 Sep; 14(6):785-790. PubMed ID: 27501713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.